Manhattan Scientifics, Inc. (MHTX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.16 Million USD | -3.85% |
| 2022 | -2.7 Million USD | 1.31% |
| 2021 | -3.61 Million USD | -1.78% |
| 2020 | 4.34 Million USD | 34.21% |
| 2019 | -1.21 Million USD | -116.88% |
| 2018 | -7.71 Million USD | 526.76% |
| 2017 | -1.42 Million USD | 73.65% |
| 2016 | -4.62 Million USD | 1.28% |
| 2015 | 9.48 Million USD | -66.76% |
| 2014 | -3.27 Million USD | -107.02% |
| 2013 | -1.58 Million USD | -7.7% |
| 2012 | -1.43 Million USD | 28.36% |
| 2011 | -2.04 Million USD | -5222.5% |
| 2010 | 40 Thousand USD | 111.05% |
| 2009 | -361 Thousand USD | 68.11% |
| 2008 | -1.88 Million USD | 69.35% |
| 2007 | -2.74 Million USD | -81.08% |
| 2006 | -1.4 Million USD | -45.34% |
| 2005 | 97 Thousand USD | 46.46% |
| 2004 | -1.92 Million USD | 6.97% |
| 2003 | -2.54 Million USD | 15.92% |
| 2002 | -3.65 Million USD | 63.06% |
| 2001 | -9.09 Million USD | -102.52% |
| 2000 | -4.49 Million USD | 51.47% |
| 1999 | -9.71 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -160 Thousand USD | 16.56% |
| 2024 Q1 | -192 Thousand USD | 24.51% |
| 2023 Q4 | -151 Thousand USD | 16.11% |
| 2023 Q1 | -186 Thousand USD | -7.51% |
| 2023 Q3 | -180 Thousand USD | 2.7% |
| 2023 Q2 | -185 Thousand USD | 0.54% |
| 2023 FY | - USD | -3.85% |
| 2022 Q4 | -173 Thousand USD | -2.98% |
| 2022 Q1 | -182 Thousand USD | -11.66% |
| 2022 FY | - USD | 1.31% |
| 2022 Q2 | -153 Thousand USD | 15.93% |
| 2022 Q3 | -168 Thousand USD | -9.8% |
| 2021 Q1 | -183 Thousand USD | -3.98% |
| 2021 Q3 | -178 Thousand USD | -12.66% |
| 2021 Q2 | -158 Thousand USD | 13.66% |
| 2021 FY | - USD | -1.78% |
| 2021 Q4 | -163 Thousand USD | 8.43% |
| 2020 Q2 | -127 Thousand USD | 26.16% |
| 2020 Q1 | -172 Thousand USD | -127.79% |
| 2020 Q4 | -176 Thousand USD | 11.11% |
| 2020 FY | - USD | 34.21% |
| 2020 Q3 | -198 Thousand USD | -55.91% |
| 2019 FY | - USD | -116.88% |
| 2019 Q4 | 619 Thousand USD | 139.55% |
| 2019 Q3 | -1.56 Million USD | -2104.23% |
| 2019 Q2 | -71 Thousand USD | -1320.0% |
| 2019 Q1 | -5000.00 USD | -100.16% |
| 2018 Q4 | 3.14 Million USD | 475.51% |
| 2018 FY | - USD | 526.76% |
| 2018 Q3 | -837 Thousand USD | -210.57% |
| 2018 Q2 | 757 Thousand USD | 407.72% |
| 2018 Q1 | -246 Thousand USD | -116.8% |
| 2017 Q4 | 1.46 Million USD | 2285.07% |
| 2017 FY | - USD | 73.65% |
| 2017 Q3 | -67 Thousand USD | 95.56% |
| 2017 Q2 | -1.5 Million USD | -15.37% |
| 2017 Q1 | -1.3 Million USD | -16.68% |
| 2016 Q4 | -1.12 Million USD | -20.8% |
| 2016 Q1 | -1.53 Million USD | -18.72% |
| 2016 FY | - USD | 1.28% |
| 2016 Q2 | -1.8 Million USD | -17.72% |
| 2016 Q3 | -928 Thousand USD | 48.64% |
| 2015 FY | - USD | -66.76% |
| 2015 Q4 | -1.29 Million USD | 4.51% |
| 2015 Q3 | -1.35 Million USD | 7.89% |
| 2015 Q2 | -1.47 Million USD | -18.36% |
| 2015 Q1 | -1.24 Million USD | -80.0% |
| 2014 FY | - USD | -107.02% |
| 2014 Q4 | -690 Thousand USD | -9.0% |
| 2014 Q3 | -633 Thousand USD | 31.49% |
| 2014 Q1 | -1.02 Million USD | -164.04% |
| 2014 Q2 | -924 Thousand USD | 9.94% |
| 2013 Q4 | 1.6 Million USD | 156.91% |
| 2013 Q3 | -2.81 Million USD | -475.66% |
| 2013 Q2 | -489 Thousand USD | -504.13% |
| 2013 Q1 | 121 Thousand USD | 128.54% |
| 2013 FY | - USD | -7.7% |
| 2012 Q4 | -424 Thousand USD | -41.81% |
| 2012 Q2 | -360 Thousand USD | 6.49% |
| 2012 Q1 | -385 Thousand USD | -10.95% |
| 2012 FY | - USD | 28.36% |
| 2012 Q3 | -299 Thousand USD | 16.94% |
| 2011 FY | - USD | -5222.5% |
| 2011 Q4 | -347 Thousand USD | 65.54% |
| 2011 Q2 | -416 Thousand USD | -49.1% |
| 2011 Q3 | -1 Million USD | -142.07% |
| 2011 Q1 | -279 Thousand USD | -135.68% |
| 2010 FY | - USD | 111.05% |
| 2010 Q4 | 782 Thousand USD | 346.69% |
| 2010 Q2 | -292 Thousand USD | -70.76% |
| 2010 Q3 | -317 Thousand USD | -8.56% |
| 2010 Q1 | -171 Thousand USD | 77.23% |
| 2009 Q2 | -189 Thousand USD | 39.81% |
| 2009 Q1 | -314 Thousand USD | -149.29% |
| 2009 FY | - USD | 68.11% |
| 2009 Q3 | 374 Thousand USD | 297.88% |
| 2009 Q4 | -751 Thousand USD | -300.8% |
| 2008 Q1 | -1.28 Million USD | 18.05% |
| 2008 Q3 | -238 Thousand USD | 2.86% |
| 2008 FY | - USD | 69.35% |
| 2008 Q4 | 637 Thousand USD | 367.65% |
| 2008 Q2 | -245 Thousand USD | 80.99% |
| 2007 Q3 | -362 Thousand USD | 74.56% |
| 2007 FY | - USD | -81.08% |
| 2007 Q4 | -1.57 Million USD | -334.53% |
| 2007 Q2 | -1.42 Million USD | -312.46% |
| 2007 Q1 | -345 Thousand USD | -142.96% |
| 2006 Q3 | -258 Thousand USD | 73.91% |
| 2006 Q4 | -142 Thousand USD | 44.96% |
| 2006 Q2 | -989 Thousand USD | -154.24% |
| 2006 FY | - USD | -45.34% |
| 2006 Q1 | -389 Thousand USD | -45.69% |
| 2005 FY | - USD | 46.46% |
| 2005 Q1 | -890 Thousand USD | -985.37% |
| 2005 Q2 | -487 Thousand USD | 45.28% |
| 2005 Q3 | -379 Thousand USD | 22.18% |
| 2005 Q4 | -267 Thousand USD | 29.55% |
| 2004 Q2 | -1.27 Million USD | -27.13% |
| 2004 Q4 | -82 Thousand USD | 70.4% |
| 2004 Q1 | -999 Thousand USD | -51.59% |
| 2004 FY | - USD | 6.97% |
| 2004 Q3 | -277 Thousand USD | 78.19% |
| 2003 Q1 | -560 Thousand USD | 46.3% |
| 2003 FY | - USD | 15.92% |
| 2003 Q4 | -639 Thousand USD | -52.19% |
| 2003 Q3 | -360 Thousand USD | 60.71% |
| 2003 Q2 | -987 Thousand USD | -74.37% |
| 2002 Q4 | -1.17 Million USD | -273.65% |
| 2002 FY | - USD | 63.06% |
| 2002 Q2 | -446 Thousand USD | 64.19% |
| 2002 Q1 | -1.23 Million USD | -126.56% |
| 2002 Q3 | -315 Thousand USD | 28.89% |
| 2001 Q1 | -1.96 Million USD | -42.95% |
| 2001 FY | - USD | -102.52% |
| 2001 Q4 | -546 Thousand USD | 41.73% |
| 2001 Q3 | -937 Thousand USD | 58.32% |
| 2001 Q2 | -2.24 Million USD | -14.29% |
| 2000 Q3 | -1.19 Million USD | -21.03% |
| 2000 Q4 | -1.37 Million USD | -14.95% |
| 2000 Q1 | -929 Thousand USD | 0.0% |
| 2000 FY | - USD | 51.47% |
| 2000 Q2 | -989 Thousand USD | -6.46% |
| 1999 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | -324.368% |
| IR-Med Inc. | -4.89 Million USD | 76.206% |
| Polarean Imaging plc | -11.19 Million USD | 89.602% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 355.23% |
| Avitar, Inc. | -1.66 Million USD | 30.208% |
| AVITA Medical, Inc. | -39.56 Million USD | 97.058% |
| Össur hf. | 137.38 Million USD | 100.847% |
| Zecotek Photonics Inc. | -3.44 Million USD | 66.185% |
| QHSLab, Inc. | -91.29 Thousand USD | -1175.016% |
| Wellstar International, Inc. | -1.35 Million USD | 14.192% |
| Össur hf. | 137.38 Million USD | 100.847% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 111.909% |
| Escalon Medical Corp. | -58.46 Thousand USD | -1891.071% |
| Aurora Spine Corporation | -454.37 Thousand USD | -156.174% |
| BrainsWay Ltd. | -2.31 Million USD | 49.632% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.37 Million USD | 87.59% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 121.081% |
| Vivos Inc. | -2.79 Million USD | 58.327% |
| MicroPort Scientific Corporation | -347.57 Million USD | 99.665% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | -488.798% |
| REMSleep Holdings, Inc. | -1.66 Million USD | 30.239% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -207.2% |
| Nanomix Corporation | -8.13 Million USD | 85.7% |
| Theraclion SA | -2.05 Million USD | 43.241% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | -64.632% |
| Positron Corporation | -1.45 Million USD | 19.843% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 32.4% |
| Lombard Medical, Inc. | -28.06 Million USD | 95.853% |
| ALR Technologies Inc. | -6.4 Million USD | 81.813% |
| Stratec SE | 39.91 Million USD | 102.916% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 1253.126% |
| Heart Tronics, Inc. | -14.85 Million USD | 92.165% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | -884.28% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 91.233% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 87.281% |
| VMS Rehab Systems, Inc. | -68.55 USD | -1697930.635% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 62.764% |
| Ingen Technologies, Inc. | -8639.00 USD | -13373.782% |
| Odyssey Group International, Inc. | -2.13 Million USD | 45.558% |
| United American Healthcare Corporation | -59 Thousand USD | -1872.881% |
| ECGI Holdings, Inc. | -2.99 Million USD | 61.076% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | -85.002% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | -126.448% |
| Urologix, Inc. | -6.34 Million USD | 81.652% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 6.081% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | -51.965% |
| SS Innovations International, Inc. | -20.37 Million USD | 94.287% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | -422.399% |
| Smith & Nephew plc | 1 Billion USD | 100.116% |
| NIOX Group Plc | 11.07 Million USD | 110.51% |
| Fuse Medical, Inc. | 1.83 Million USD | 163.422% |
| Broncus Holding Corporation | -25.19 Million USD | 95.381% |
| Brain Scientific Inc. | -7.93 Million USD | 85.328% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 87.605% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | -6226.087% |